Yolanda María Pacheco

Yolanda María Pacheco

Auto-generated profile, based on publicly available information

Yolanda María Pacheco

Inmunology Service, Laboratory of Immunology, UGC Clinical Laboratories, Institute of Biomedicine of Seville (IBiS)/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
BBBeatriz Bermudez
Beatriz Bermudez
SLSergio Lopez
Sergio Lopez
AOAlmudena Ortega-Gomez
Almudena Ortega-Gomez
LVLOURDES M VARELA
LOURDES M VARELA
YPYolanda M. Pacheco
Yolanda M. Pacheco
FMFrancisco J.G. Muriana
Francisco J.G. Muriana
Traditionally, nutrients such as fatty acids have been viewed as substrates for the generation of high-energy molecules and as precursors for the biosynthesis of macromolecules. However, accumulating data from multiple lines of evidence suggest that dietary fatty acids are linked not only to health promotion but also to disease pathogenesis. Metabolism in humans is regulated by complex hormonal signals and substrate interactions. For many years, the clinical focus has centered on a wide metabolic picture after an overnight fast. Nonetheless, the postprandial state (i.e., "the period that comprises and follows a meal") is an important one, and silent disturbances in this period are involved in the genesis of numerous pathological conditions, including atherosclerosis. In this review article, we present an overview of the evidence demonstrating the relevance of oleic acid in olive oil on different nutrition-related issues. We also discuss the impact of oleic acid in olive oil and its clinical relevance to major risk factors for cardiovascular disease in the context of the postprandial state and with regard to other dietary fatty acids.

15 January 2013 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
GMGema Méndez-Lagares
Gema Méndez-Lagares
MRM. Concepción Romero-Sánchez
M. Concepción Romero-Sánchez
EREzequiel Ruiz-Mateos
Ezequiel Ruiz-Mateos
MGMiguel Genebat
Miguel Genebat
SFSara Ferrando-Martínez
Sara Ferrando-Martínez
MLManuel Leal
Manuel Leal
Levels of soluble CD14 (sCD14) were longitudinally measured in 85 human immunodeficiency virus (HIV)–infected subjects during long-term receipt of suppressive combined antiretroviral therapy (cART) and compared to those in young and elderly HIV-negative control subjects. cART did not normalize sCD14 levels; rather, the HIV-infected group displayed a significantly higher sCD14 level at baseline (ie, before cART initiation), 1 year after cART initiation, and 5 years after cART initiation, compared with both control groups. Furthermore, the baseline CD4+ T-cell count was inversely associated with the baseline sCD14 level. Our results point to the necessity of complementary therapies to treat the activated/inflamed status associated with chronic HIV infection and to the benefits of early initiation of cART.

1 March 2011 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SLSergio Lopez
Sergio Lopez
BBBeatriz Bermudez
Beatriz Bermudez
AOAlmudena Ortega-Gomez
Almudena Ortega-Gomez
LVLOURDES M VARELA
LOURDES M VARELA
YPYolanda M Pacheco
Yolanda M Pacheco
FMFrancisco Jg Muriana
Francisco Jg Muriana
Background: The nature of dietary fats and fasting concentrations of triglycerides affect postprandial hypertriglyceridemia and glucose homeostasis.

1 May 2015 in Antiviral Research
Verified
Journal Article
Closed access
YPY.M. Pacheco
Y.M. Pacheco
IJI. Jarrin
I. Jarrin
IRI. Rosado
I. Rosado
ACA.A. Campins
A.A. Campins
JBJ. Berenguer
J. Berenguer
MLM. Leal
M. Leal

21 March 2008 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
BBBeatriz Bermúdez
Beatriz Bermúdez
SLSergio Lopez
Sergio Lopez
YPYolanda M. Pacheco
Yolanda M. Pacheco
JVJosé Villar
José Villar
FMFrancisco J.G. Muriana
Francisco J.G. Muriana
RARocío Abia
Rocío Abia
Postprandial triglyceride-rich lipoproteins (TRL) have a direct effect on vascular smooth muscle cells (SMC) and they increase the risk of atherogenesis. Here, we have tested the hypothesis that the different fatty acid composition of TRL is capable of differentially modifying gene expression in human coronary artery SMC (CASMC). In addition, the effect of TRL on cell proliferation and transcription factor activation was also evaluated. TRL were prepared from plasma of healthy volunteers after the ingestion of meals enriched in refined olive oil (ROO), butter or a mixture of vegetable and fish oils (VEFO). We use cDNA microarrays to determine the genes differentially expressed in TRL-treated CASMC. Correspondence cluster analysis demonstrated that TRL-butter, -ROO and -VEFO provoked different transcriptional profiles in CASMC. Sixty-six genes were regulated by TRL-butter, 55 by –ROO, and 47 by -VEFO. The data revealed that TRL-butter predominantly activated genes involved in the regulation of cell proliferation and inflammation. Likewise, TRL-VEFO induced the expression of genes implicated in inflammation, while TRL-ROO promoted a less atherogenic gene profile. The pathophysiological contribution of TRL to the development of atherosclerosis and the stability of atherosclerotic plaques may depend on the fatty acid composition of TRL. Our findings suggest a role for macrophage-inhibiting cytokine-1 (MIC-1) in coronary artery cardiovascular events.

26 May 2021 in Aging
Verified
Journal Article
Open access
VGVanesa Garrido-Rodríguez
Vanesa Garrido-Rodríguez
IHInés Herrero-Fernández
Inés Herrero-Fernández
MCMaría José Castro
María José Castro
ACAna Castillo
Ana Castillo
IRIsaac Rosado-Sánchez
Isaac Rosado-Sánchez
YPYolanda María Pacheco
Yolanda María Pacheco
The CD4/CD8 T-cell ratio is emerging as a relevant marker of evolution for many pathologies and therapies. We aimed to explore immunological features beyond CD4/CD8 ratio values in older subjects (>65 years old) who were classified as having lower (2) ratio values. The lower group showed a lower thymic output (sj/β-TREC ratio) and frequency of naïve T-cells, concomitant with increased mature T-cells. In these subjects, the CD4 T-cell subset was enriched in CD95+ but depleted of CD98+ cells. The regulatory T-cell (Treg) compartment was enriched in CTLA-4+ cells. The CD8 T-cell pool exhibited increased frequencies of CD95+ cells but decreased frequencies of integrin-β7+ cells. Interestingly, in the intermediate group, the CD4 pool showed greater differences than the CD8 pool, mostly for cellular senescence. Regarding inflammation, only hsCRP was elevated in the lower group; however, negative correlations between the CD4/CD8 ratio and β2-microglobulin and sCD163 were detected. These subjects displayed trends of more comorbidities and less independence in daily activities. Altogether, our data reveal different thymic output and immune profiles for T-cells across CD4/CD8 ratio values that can define immune capabilities, affecting health status in older individuals. Thus, the CD4/CD8 ratio may be used as an integrative marker of biological age.